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Dysregulation of Parvalbumin
Expression in the Cntnap2−/−
Mouse Model of Autism Spectrum
Disorder
Emanuel Lauber, Federica Filice and Beat Schwaller*
Anatomy Unit, Section of Medicine, University of Fribourg, Fribourg, Switzerland
Due to the complex and heterogeneous etiology of autism spectrum disorder (ASD),
identification of convergent pathways and/or common molecular endpoints in the
pathophysiological processes of ASD development are highly needed in order to
facilitate treatment approaches targeted at the core symptoms. We recently reported
on decreased expression of the Ca2+-binding protein parvalbumin (PV) in three
well-characterized ASD mouse models, Shank1−/−, Shank3B−/− and in utero VPA-
exposed mice. Moreover, PV-deficient mice (PV+/− and PV−/−) were found to
show behavioral impairments and neuroanatomical changes closely resembling those
frequently found in human ASD individuals. Here, we combined a stereology-based
approach with molecular biology methods to assess changes in the subpopulation of
PV-expressing (Pvalb) interneurons in the recently characterized contactin-associated
protein-like 2 (Cntnap2−/−) knockout mouse model of ASD. The CNTNAP2 gene
codes for a synaptic cell adhesion molecule involved in neurodevelopmental processes;
mutations affecting the human CNTNAP2 locus are associated with human ASD
core symptoms, in particular speech and language problems. We demonstrate that
in Cntnap2−/− mice, no loss of Pvalb neurons is evident in ASD-associated brain
regions including the striatum, somatosensory cortex (SSC) and medial prefrontal cortex
(mPFC), shown by the unaltered number of Pvalb neurons ensheathed by VVA-positive
perineuronal nets. However, the number of PV-immunoreactive (PV+) neurons and also
PV protein levels were decreased in the striatum of Cntnap2−/− mice indicating that
PV expression levels in some striatal Pvalb neurons dropped below the detection
limit, yet without a loss of Pvalb neurons. No changes in PV+ neuron numbers were
detected in the cortical regions investigated and also cortical PV expression levels
were unaltered. Considering that Cntnap2 shows high expression levels in the striatum
during human and mouse embryonic development and that the cortico-striato-thalamic
circuitry is important for speech and language development, alterations in striatal PV
expression and associated (homeostatic) adaptations are likely to play an important role
in Cntnap2−/− mice and, assumingly, in human ASD patients with known Cntnap2
mutations.
Keywords: parvalbumin interneurons, calcium-binding proteins, contactin-associated protein-like 2, autism
spectrum disorder, hyperpolarization-activated cyclic nucleotide-gated channels, perineuronal nets
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INTRODUCTION
The etiology of autism spectrum disorder (ASD) is highly
complex and diverse. A combination of genetic, epigenetic and
environmental factors is assumed to ultimately lead to the ASD
phenotype characterized by impairments in social interaction
and language/communication, and the presence of restricted
or stereotyped patterns of behavior (Kleijer et al., 2014). The
genetic architecture of ASD is extremely heterogeneous and
difficult to apprehend. Common, rare, and de novo mutations
are known to contribute to the genetic risk of ASD and
the number of risk genes is steadily increasing (Bourgeron,
2015). Amongst the identified ASD risk genes, contactin-
associated protein-like 2 (Cntnap2), coding for a synaptic cell
adhesion molecule, is listed as a “strong candidate (2S)” in
the Simons Foundation Autism Research Initiative database
(SFARI)1. The CNTNAP2 gene is one of the largest genes
in humans spanning 2.3 Mb of genomic DNA, thus with
an increased probability of structural rearrangements such as
copy number variations (CNVs), insertions or deletions, single
nucleotide polymorphisms (SNPs), altered transcription factor
binding and epigenetic modifications affecting the CNTNAP2
locus (Poot, 2015). Several studies identified CNVs, common
and rare SNPs and/or polymorphisms in the CNTNAP2
locus associated with syndromic neurodevelopmental disorders
such as cortical dysplasia-focal epilepsy (CDFE) syndrome
(Strauss et al., 2006), Pitt-Hopkins syndrome (Zweier et al.,
2009), Gilles de la Tourette syndrome (Belloso et al., 2007),
intellectual disability (ID) (Mikhail et al., 2011), obsessive
compulsive disorder (Verkerk et al., 2003), attention deficit
hyperactivity disorder (ADHD) (Elia et al., 2010), schizophrenia
(Friedman et al., 2008) and autism (Alarcon et al., 2008;
Arking et al., 2008). Although patients with CNTNAP2
mutations display a complex phenotype, most of these patients
manifest autistic characteristics; language impairments such as
dysarthric language, language delay or absent speech/language
are particularly frequent (Rodenas-Cuadrado et al., 2014;
Penagarikano et al., 2015). Accordingly, Cntnap2−/− mice
show impairments in social behavior and reduced vocalizations
(Penagarikano et al., 2011; Brunner et al., 2015; Liska et al.,
2017), deficits in learning and memory (Rendall et al., 2016) and
epileptiform activity (Penagarikano et al., 2011; Thomas et al.,
2016).
Due to the complex and heterogeneous etiology of ASD,
major efforts are aimed to possibly identifying convergent
pathways across different ASD mouse models in order to
facilitate treatment approaches. One cell type, whose function
is consistently impaired in different ASD mouse models (Wöhr
et al., 2015) and post-mortem brains of human ASD patients
(Hashemi et al., 2016) and thus representing a promising
point-of-convergence with respect to ASD heterogeneity is
a subset of GABAergic interneurons expressing parvalbumin
(PV); hereafter termed Pvalb neurons. PV is a slow-onset
Ca2+ buffer (more precisely described as a neuronal Ca2+
signal modulator) and a characteristic marker for fast-spiking
1https://gene.sfari.org
interneurons (FSI). The number of Pvalb neurons (solely based
on PV immunohistochemistry) was reported to be decreased
in the cortex, striatum and hippocampus of Cntnap2−/−
mice compared to WT mice (Penagarikano et al., 2011).
However, we have shown in several validated ASD mouse
models that the previously described “loss” of Pvalb neurons
is caused by the down-regulation of PV in some neurons
below a detectable threshold, while the number of Pvalb
neurons is unchanged (Filice et al., 2016; Lauber et al., 2016).
This is of great functional importance and was consistently
found in PV+/−, PV−/−, Shank1−/−, Shank3B−/− and
in utero VPA-exposed mice (VPA) mice; the genetic ASD
mouse models also listed in the SFARI database. Here we
show that the number of Pvalb neurons, identified by Vicia
Villosa Agglutinin-positive (VVA+) perineuronal nets (PNN),
is unchanged in Cntnap2−/− compared to WT mice in the
somatosensory cortex, medial prefrontal cortex and striatum,
three brain regions often implicated in ASD pathophysiology.
However, decreased protein expression of PV was detected
exclusively (selectively) in the striatum of Cntnap2−/− mice,
as before in Shank3B−/− and VPA mice (Filice et al.,
2016; Lauber et al., 2016), further supporting the hypothesis
that PV down-regulation represents a common molecular
endpoint across different ASD models. These findings thus
closely link the Cntnap2−/− model with other previously
validated ASD mouse models such as Shank3B−/− and VPA
mice.
MATERIALS AND METHODS
Animals
Mice were group-housed at the University of Fribourg,
Switzerland, in temperature-controlled animal facilities
(24◦C, 12:12 h light/dark cycle). Mice had free access to
water and were fed ad libitum. C57Bl/6J (WT), B6.129(Cg)-
Cntnap2tm1Pele/J (Cntnap2−/−), B6.129-Shank3tm2Gfng/J
(Shank3B−/−) mice were purchased from Jackson Laboratory
(Bar Harbor, ME, United States). B6.Pvalbtm1Swal (PV−/−)
mice were generated by homologous recombination as
described before (Schwaller et al., 1999). All strains were
backcrossed to C57Bl/6J for more than ten generations
and therefore considered congenic with C57Bl/6J. Thus,
alterations at the level of morphology, biochemistry and
molecular biology are assumed to be the result of genotypic
differences and not related to mouse strain. Pups obtained
from at least 3 different litters per group were used in
order to exclude a litter bias. Mice were euthanized either
with Esconarkon (300 mg/kg body weight; Streuli Pharma
AG, Uznach, Switzerland) for subsequent perfusion, or by
cerebral dislocation, if followed by dissection and isolation
of selected brain regions. Only male mice participated in the
experiments. All experiments were executed with the permission
of the local animal care committee (Canton of Fribourg,
Switzerland) and according to the present Swiss law and the
European Communities Council Directive of 24 November 1986
(86/609/EEC).
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Tissue Preparation and
Immunohistochemistry
Mice were anesthetized and perfused using 0.9% NaCl solution
followed by 4% paraformaldehyde (PFA). Brains were removed
and post-fixed in 4% PFA at RT for 24 h before they were
transferred to 30% sucrose-TBS 0.1 M, pH 7.3 solution for
cryopreservation at 4◦C. After cryopreservation, brains were cut
coronally in rostro-caudal direction using a freezing microtome
(Frigomobil, Reichert-Jung, Vienna, Austria). Following
stereological systematic random sampling principles, every sixth
section was collected. Floating sections were then blocked for
1 h at RT in TBS 0.1 M, pH 7.3 containing 10% bovine serum
albumin (BSA) and 0.4% Triton X-100. Afterward, sections
were rinsed 3 times in TBS before being incubated using a
PV antibody (anti-rabbit PV25, Swant, Marly, Switzerland)
diluted 1:1000 and Vicia Villosa Agglutinin (biotinylated-
VVA, Reactolab, Servion, Switzerland) at 10 µg/ml in TBS
containing MgCl2, MnCl2, CaCl2 (final salt concentration:
0.1 mM each) for 16 h at 4◦C. Next, sections were washed
once in TBS and twice in Tris-HCl 0.1 M, pH 8.2 before
incubation with the following antibodies: anti-rabbit Cy3-
conjugated (diluted 1:200) and Cy2 streptavidin-conjugated
(diluted 1:200, Milan Analytic AG, Switzerland) in Tris-HCl
for 2 h at RT protected from light. After rinsing, sections
were stained with DAPI (diluted 1:1000; LuBio Science
GmbH, Luzern, Switzerland) in PBS 0.1 M, pH 7.4. After
final rinsing, sections were mounted and cover-slipped using
Hydromount mounting medium (National Diagnostics, Atlanta,
GA, United States).
Stereological Quantification and
Counting Criteria
A Stereo Investigator system (Version 11, MicroBrightField,
Williston, VT, United States) coupled to a Zeiss Axioplan
microscope carrying a motorized x-y stage (Ludl Electronic
Products, Ltd, Hawthorne, NY, United States) and connected
to a Hamamtsu Orca Camera was used. Estimation of
the total number of PV-positive (PV+) and Vicia Villosa
Agglutinin-binding (VVA+) cells in pre-defined brain regions
of interest (ROIs) was performed using the optical fractionator
method (West et al., 1991) as described previously (Lauber et al.,
2016). Stereotactic coordinates provided by the Paxinos and
Franklin atlas (Paxinos, 2001) were used to define ROIs. The
striatum (caudate-putamen) was defined at 1.10 to −0.82 mm
from bregma, the SSC at 1.94 to −1.82 mm from bregma and
the mPFC at 1.94 to 1.10 mm from bregma. Cell counting
was performed on images obtained with the following objective
lenses: 100x; NA = 1.40, oil immersion for the SSC; and
63x; NA = 1.30, oil immersion for the mPFC and striatum.
The Cavalieri estimator (Gundersen et al., 1988) was used
to estimate the total volume of the analyzed ROI. 6 WT
mice and 5 Cntnap2−/− mice including pups obtained from
at least three different litters per group were analyzed. All
stereological parameters and results are reported in Tables 1, 2,
respectively.
PV+ and VVA+ cells were quantified independently and
according to the following criteria: (1) presence of a DAPI-stained
nucleus; (2) well-defined and roundish perineuronal net (PNN)
for VVA+ cells; (3) nucleus-surrounding PV staining for PV+
TABLE 1 | Stereological sampling parameters.
Brain
region
Cutting
plane
No. of
sections
Section
evaluation
interval (µm)
Height of
disector (µm)
Guard zone
(µm)
Counting
frame area
(µm)
Sampling
grid area
(µm)
Measured
section
thickness
mean (µm)
Cavalieri grid
size (µm)
Striatum coronal 6–7 6 20.0 0.5 110 × 90 350 × 350 21.61 150 × 150
SSC coronal 14–15 6 20.0 0.5 70 × 55 450 × 450 21.35 200 × 200
mPFC coronal 4 6 20.0 0.5 90 × 70 150 × 200 20.55 100 × 100
TABLE 2 | Mean total number of PV+ and VVA+ cells in the striatum, SSC and mPFC of WT and Cntnap2−/− mice.
Mean SD P-value CEm = 0/m = 1 ≤ Mean SD P-value CEm = 0/m = 1 ≤
Striatum PV+ Striatum VVA+
WT 21’298 948 0.10/0.06 26’413 486 0.10/0.06
KO 17’260 1’033 0.0001 0.13/0.08 26’461 2’241 0.9637 0.11/0.06
SSC PV+ SSC VVA+
WT 122’203 4’497 0.07/0.06 146’108 9’824 0.06/0.05
KO 118’656 8’590 0.4386 0.07/0.05 152’001 7’832 0.3259 0.06/0.05
mPFC PV+ mPFC VVA+
WT 6’572 248 0.11/0.07 7’170 645 0.10/0.07
KO 6’920 801 0.3359 0.12/0.07 7’350 801 0.6892 0.12/0.07
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FIGURE 1 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the striatum of PND25 WT (N = 6) and Cntnap2−/− (N = 5) mice. Middle:
percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in WT and KO mice. Right: Volume of the ROI; i.e., the striatum.
Asterisks represent ∗∗∗P < 0.001. (B) Representative immunofluorescence images of PV (red) and VVA (green) co-localization from PND25 mouse striatum are
shown. Less VVA+ cells are also positive for PV in Cntnap2−/− compared to WT mice (outlined by arrowheads). (C) Representative PV immunofluorescence images
from the striatum of a WT and Cntnap2−/− mouse. ROIs are indicated with dashed lines (sections are located at Bregma 0.38 and 0.14 mm, respectively). Scale
bar: (B) 50 µm; (C) 500 µm. All data are expressed as mean ± SEM.
neurons. Examples are shown in Figure 1B. At every fifth
sampling location, the section thickness was measured and the
mean of all measurements was used for computations. The total
number of cells (N) in a defined ROI was estimated as proposed
by West et al. (1991, 1996) using the formula:
N =
∑
Q− × (1/ssf )× (1/asf )× (1/tsf )
where Q− stands for “tops” (counts), and asf, tsf, and ssf for
area sampling fraction, thickness sampling fraction and section
sampling fraction, respectively. The coefficient of error CE was
used to evaluate the precision of the estimates (Gundersen et al.,
1999). CEs (m = 1 and m = 0) are provided in Table 2. To ensure
independent and unbiased cell estimates, PV+ or VVA+ cells
were quantified without cross-checking the other channel.
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TABLE 3 | RT-qPCR primers.
Primer Sequence 5′ – 3′ Nt position Gene Gene accession number
18S rRNA For: TCAAGAACGAAAGTCGGAGGTT 1026–1047 Rn18S NR_003278
Rev: GGACATCTAAGGGCATCACAG 1493–1513
GAD67 For: AATCTTGCTTCAGTAGCCTTCG 2979–3000 Gad1 NM_001312900
Rev: TGTCTTCAAAAACACTTGTGGG 3178–3199
GAPDH For: ACCACAGTCCATGCCATCAC 612–631 Gapdh NM_001289726
Rev: CACCACCCTGTTGCTGTAGCC 1041–1061
HCN1 For: CTCAGTCTCTTGCGGTTATTACG 1138–1160 Hcn1 NM_010408
Rev: TGGCGAGGTCATAGGTCAT 1210–1228
HCN2 For: ATCGCATAGGCAAGAAGAACTC 1936–1957 Hcn2 NM_008226
Rev: CAATCTCCTGGATGATGGCATT 2017–2037
HCN4 For: GCATGATGCTTCTGCTGTGT 1268–1287 Hcn4 NM_001081192
Rev: GCTTCCCCCAGGAGTTATTC 1371–1390
Kv3.1 For: GTGCCGACGAGTTCTTCTTC 1362–1381 Kcnc1 NM_001112739
Rev: GTCATCTCCAGCTCGTCCTC 1646–1665
Kv3.2 For: AGATCGAGAGCAACGAGAGG 72–91 Kcnc2 NM_001025581
Rev: GGTGGCGATCGAAGAAGAAT 379–398
Kv9.3 For: CCCTGGACAAGATGAGGAAC 465–484 Kcns3 NM_173417
Rev: TTGATGCCCCAGTACTCGAT 745–764
Pvalb For: TGTCGATGACAGACGTGCTC 24–43 Pvalb NM_013645
Rev: TTCTTCAACCCCAATCTTGC 309–328
RT-qPCR
After euthanasia by cervical dislocation, the whole brain of mice
was quickly removed and put into ice-cold 0.9% NaCl solution
for dissection. After cutting the brain in half along the midline,
the cerebellum was removed. Next, the hippocampus followed
by the striatum were dissected by carefully removing (pulling)
the tissue pieces as described previously (see Figure S2 in Lauber
et al., 2016). Unlike in our previous studies, exclusively cortical
tissue was obtained by removing the remaining parts of the brain
such as thalamus and fiber tracts from the cortex. Tissue samples
were separately snap-frozen using liquid nitrogen before storing
them at −80◦C. Since RNA is more prone to degradation, the
left hemisphere of the brain was dissected first and afterward
used for RT-qPCR analysis. RNA was extracted from tissue pieces
with the peqGold TRIzol reagent (Peqlab, VWR International
GmbH, Erlangen, Germany). Promega’s Reverse Transcription
Kit (Promega, Dübendorf, Switzerland) was used to synthesize
cDNA. RT-qPCR to examine mRNA expression levels for Gapdh,
Rn18S, Pvalb, Gad67, Hcn1, Hcn2, Hcn4, Kcnc1, Kcnc2, and
Kcns3 genes was performed using the universal 2X KAPA SYBR
FAST qPCR Master Mix (Axonlab AG, Mont-sur-Lausanne,
Switzerland) and a DNA thermal cycler (Corbett Rotor gene
6000, QIAGEN Instruments AG, Hombrechtikon, Switzerland).
Primer sequences and PCR products are reported in Table 3.
After initial denaturation at 95◦C for 3 min, a two-step
protocol was run: 40 cycles comprising denaturation at 95◦C
for 3 s and annealing/extension/data acquisition between 54
and 60◦C for 20 s. The housekeeping genes Gapdh (striatum)
and Rn18S (18S rRNA) (cortex) were used to normalize the
mRNA content for each sample. Finally, the 2− 11Ct method
was used to quantify mRNA levels and genes of interest were
normalized to I) the housekeeping gene and II) the control, i.e.,
wild-type group as previously described (Livak and Schmittgen,
2001).
Western Blot Analysis
Tissue samples from the right hemispheres were sonicated
and soluble proteins extracted for Western blotting. Proteins
(30 µg/sample) were separated under denaturing conditions
by SDS-PAGE (12.5%). Following gel electrophoresis,
semi-dry transfer was performed to transfer proteins onto
nitrocellulose membranes (MS solution, Chemie Brunschwig,
Basel, Switzerland). The membranes were initially blocked
at RT for 1 h in 5% BSA in TBS 0.1 M, pH 7.6 followed by
incubation with primary antibodies: rabbit anti-PV25 (Swant,
Marly, Switzerland), rabbit anti-GAPDH (Sigma-Aldrich,
Buchs, Switzerland) both diluted 1:10,000 in TBS with 0.1%
Tween (TBS-T) and 2% BSA overnight at 4◦C. On the next
day, membranes were rinsed 3 times with TBS-T before
being incubated for 1 h at RT in the secondary antibody
containing solution: goat anti-rabbit IgG HRP-conjugated
(Sigma–Aldrich, Buchs, Switzerland) diluted 1:10,000 in TBS-T.
Finally, membranes were washed 3 times with TBS before
development using ECL (Merck Millipore, Schaffhausen,
Switzerland). Image Studio Light Version 5.0 software was used
to quantify visualized bands. GAPDH bands served as loading
control on all membranes.
Statistical Analysis and Cell Number
Estimates
A two-tailed, unpaired t-test was used to compare stereological
data, mRNA and protein levels between the two groups.
Data were analyzed using the R version 3.3.3 software.
Stereological data from the two hemispheres of the same
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mouse were pooled and analyzed together. A p-value < 0.05 was
considered to be statistically significant.
RESULTS
Unaltered Numbers of Pvalb Neurons,
but Decreased PV Expression Levels in
the Striatum of Cntnap2−/− Mice
Unbiased stereological analysis of brain sections obtained from
postnatal day (PND) 25 ± 1 control C57Bl/6J (WT) and
Cntnap2−/− mice was aimed to obtain robust and precise
cell number and volume estimates in different brain regions.
The optical fractionator method and the Cavalieri estimator
were used to quantify cell numbers and volumes in the
striatum, somatosensory cortex (SSC) and medial prefrontal
cortex (mPFC), three brain regions frequently implicated in
ASD pathology. Coefficient of error (CE) values ranged from
0.05 to 0.11 for the WT group and from 0.05 to 0.13 for the
Cntnap2−/− group; all stereological parameters and results are
reported in Tables 1, 2, respectively. We independently quantified
the number of parvalbumin-positive (PV+) and Vicia Villosa
Agglutinin-positive (VVA+) cells in the same regions of interest
as described before (Filice et al., 2016; Lauber et al., 2016).
VVA recognizes N-acetylgalactosamine residues on the surface
of perineuronal nets (PNN), which preferentially surround Pvalb
neurons (Hartig et al., 1992; Haunso et al., 2000). Thus, Pvalb
neurons with strongly decreased PV expression levels (i.e., below
the detectable threshold) or even completely devoid of PV, may
still be detected by the VVA+ staining as previously shown in
PV+/− and PV−/−mice, respectively (Filice et al., 2016). In line
with previous findings in Cntnap2−/−mice that reported a∼20–
25% decrease in the number of PV+ neurons in the striatum,
cortex and hippocampus at PND14 (Penagarikano et al., 2011),
we found a significant decrease in the order of 20% (p = 0.0001)
in the total number of PV+ cells in the striatum of PND25
Cntnap2−/− mice compared to WT mice. Yet the total number
of VVA+ cells was unchanged between the two genotypes,
indicating that there was no loss of Pvalb neurons in the
striatum of Cntnap2−/− mice (Figure 1A). This conclusion was
confirmed by the percentage of double-positive cells. As observed
in WT mice,∼90% of PV+ cells were also VVA+ in Cntnap2−/−
mice; however, only ∼58% of cells out of the VVA pool were
detected as PV+ cells in Cntnap2−/− mice (∼72% in WT),
indicating that ∼15% (p = 0.0002) of VVA+ cells had “lost” their
PV signal compared to WT mice (Figure 1A). Representative
immunofluorescence images of VVA+, PV+ and double-positive
cells in the striatum are shown in Figures 1B,C, respectively. The
VVA+ immunofluorescence images corresponding to Figure 1C
are shown in Supplementary Figure 1. It is evident that while
almost all VVA+ cells co-localized with PV+ cells in the WT
group resulting in red-fluorescent cells with a “yellow rim,”
several VVA+ cells were PV-immuno-negative (“green only”) in
the striatum of Cntnap2−/−mice (Figure 1B). The mean volume
of the striatum, as determined using the Cavalieri estimator, was
unchanged between the two genotypes (Figure 1A).
RT-qPCR and Western blot analysis of striatal tissue revealed
changes in PV protein expression levels between WT and
Cntnap2−/−mice. The trend toward a decrease in Pvalb mRNA
levels in Cntnap2−/− mice measured by RT-qPCR did not
reach statistical significance compared to WT samples (∼10%,
p = 0.3190) (Figure 2A). But more importantly at the functional
level and consistent with the stereological analysis, Western
blot analysis of Cntnap2−/− striatal lysates revealed a ∼22%
(p = 0.0219) decrease in PV protein levels compared to WT
(Figure 2B; uncropped images of all Western blots are shown
in Supplementary Figure 2). Representative protein Western
blot signals for PV and GAPDH are shown in Figure 2B.
Taken together, these results confirm that Cntnap2−/− mice
exhibit striatal PV down-regulation during early post-natal
development without any indication for Pvalb neuronal loss. The
non-significant decrease in Pvalb transcript levels hints toward a
possible post-transcriptional regulation, unlike in the previously
investigated ASD mouse models Shank3B−/− and VPA mice,
where both Pvalb transcript and PV protein levels were decreased
to a similar extent (Filice et al., 2016; Lauber et al., 2016).
To further support that the total number of striatal Pvalb
neurons was unchanged between the two groups, mRNA
levels for typical universal GABAergic interneuron markers
and Pvalb neuron-specific markers were investigated. Glutamate
decarboxylase isoform 67 (Gad67) mRNA levels were not
significantly different between WT and Cntnap2−/− mice
(Figure 2C). Of note, Gad67 is not exclusively expressed in Pvalb
neurons, but also in other interneurons. Thus, additional Pvalb
neuron-specific markers were analyzed including the potassium
voltage-gated channels subfamily C member 1 (Kcnc1), the
protein also known as Kv3.1 (Chow et al., 1999) and subfamily
S member 3 (Kcns3) coding for Kv9.3 (Georgiev et al., 2012).
Both potassium channel transcripts were found to be unaltered
between WT and Cntnap2−/−mice (Figure 2D). The same held
true for Kcnc2 (Kv3.2) (Figure 2D), the next closest relative of
Kcnc1, which also co-localizes with Pvalb neurons but to a lesser
extent than Kcnc1 (Chow et al., 1999).
In an exploratory approach, we quantified mRNA levels
for hyperpolarization-activated cyclic nucleotide-gated (HCN)
channel isoforms 1, 2, and 4. HCN channel expression and/or the
currents mediated by these channels (Ih current) were previously
reported to be altered in cultured hippocampal neurons derived
from Shank3−/−mice (Yi et al., 2016) and in VPA mice (Lauber
et al., 2016), two validated mouse ASD models with a similar
striatal PV deficit as the Cntnap2−/− mice. While Hcn1 and
Hcn2 mRNA expression levels in Cntnap2−/− mice did not
differ from transcript levels in WT mice in the striatum, Hcn4
mRNA levels were significantly decreased by ∼40% (p = 0.0418)
in Cntnap2−/− mice (Figure 2E). The conceivable functional
implications of these results are discussed below.
Lack of Cntnap2 Has No Effect on the
Number of Pvalb Neurons and PV
Expression in SSC and mPFC
Unlike previously reported by Penagarikano et al. (2011) and by
Vogt et al. (2017) in the SSC of PND14 and PND30 Cntnap2−/−
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FIGURE 2 | RT-qPCR values from striatal samples of PND25 mice representing mRNA levels for (A) Pvalb, (C) Gad67, (D) Left: Kcnc1; Middle: Kcnc2; Right: Kcns3,
(E) Left: Hcn1; Middle: Hcn2; Right: Hcn4. Signals were normalized to Gapdh mRNA levels and expressed as fold change compared to WT (N = 6 mice each).
(B) Left: Quantitative Western blot analysis of striatal samples of PND25 WT and Cntnap2–/– mice (N = 6 mice each). Quantification of PV protein levels in the
striatum is shown. Asterisks represent ∗P ≤ 0.05. GAPDH signals served as loading controls and were used for the normalization of PV protein signals. Results are
expressed as a percentage of normalized PV/GAPDH signals in the WT group. Right: Representative Western blot signals for PV and GAPDH are shown. All data are
expressed as mean ± SEM.
mice, respectively, we did not find Pvalb neuron-specific
alterations in the cortex of the same mice at PND25. Neither
were PV+ cell numbers altered in the SSC and mPFC, nor
did we observe differences in the number of VVA+ cells in
the same brain regions (Figures 3A, 4A). Accordingly, the
percentage of double-positive cells, in both directions (PV pool
and VVA pool), was not significantly altered between WT and
Cntnap2−/− mice in the SSC and mPFC (Figures 3A, 4A).
The volumes of the SSC and mPFC were also similar between
groups (Figures 3A, 4A). Representative immunofluorescence
images of the SSC and mPFC are depicted in Figures 3B, 4B,
respectively. In agreement with the unchanged numbers of Pvalb
neurons, subsequent mRNA and protein quantification showed
that Pvalb transcript and PV protein levels were essentially
identical between WT and Cntnap2−/− mice in cortical tissue
obtained from male PND25 mice (Figures 5A,B). Similarly,
PV protein levels in the hippocampus and cerebellum were
not different between genotypes at PND25 (Supplementary
Figure 3). RT-qPCR analysis of cortical tissue confirmed the
stereological findings. No alterations in the mRNA levels for
Gad67, Kcnc1, Kcnc2, and Kcns3 were observed in cortical
extracts from Cntnap2−/− mice at PND25 (Figures 5C,D).
Concomitantly, mRNA levels for the three HCN family members
were unchanged in the cortex of Cntnap2−/− mice (Figure 5E).
We had previously reported about increased Hcn1 mRNA levels
in the cortex of VPA mice, which might thus explain some of the
electrophysiological deficits that have previously been found in
this ASD model (Rinaldi et al., 2007, 2008; Lauber et al., 2016).
Unchanged Transcript Levels of Pvalb
Neuron Markers Kcnc1 and Kcns3, as
Well as Hcn Family Members in Adult
(PND70) Cntnap2−/− Mice
The role of Cntnap2 in the regulation and electrophysiological
properties of Pvalb neurons had been investigated previously.
Vogt et al. (2017) had used a cell transplantation approach,
where neurons from the medial ganglionic eminence (MGE)
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FIGURE 3 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the SSC of PND25 WT (N = 6) and Cntnap2–/– (N = 5) mice. Middle:
percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in WT and Cntnap2–/– mice. Right: Volume of the ROI; i.e., the
SSC. (B) Representative PV immunofluorescence images from the SSC of a WT and Cntnap2–/– mouse. ROIs are indicated with dashed lines (sections are located
at Bregma –1.34 mm). Scale bar: 500 µm. All data are expressed as mean ± SEM.
of E13.5 Cntnap2+/+, Cntnap2+/− and Cntnap2−/− mice
were transplanted into the cortex of PND1 WT mice.
These tdTomato-tagged neurons gave rise also to Pvalb
neurons evidenced by their fast, non-accommodating firing
properties. After 6–8 weeks in vivo, several electrophysiological
parameters were found to be different, depending on whether
the MGE-derived Pvalb neurons were from Cntnap2+/+ or
Cntnap2−/− mice. In neurons from the latter, the resting
membrane potential was more positive, the AP spike half-width
increased, the maximum AP slope decreased, and also the input
resistance was slightly increased; the authors had hypothesized
that these changes might be caused by alterations in K+ and/or
Na+ channels. Since changes related to K+ conductances had
been observed in striatal neurons with reduced or absent PV
expression (e.g., higher firing frequency, increased excitability,
slower AHP recovery, more regular inter spike interval) (Bischop
et al., 2012; Orduz et al., 2013), we performed Western
blot analysis of cortical extracts obtained from adult mice
(PND70 ± 1). However, we found no evidence for reduced PV
levels in the cortex of PND70 Cntnap2−/−mice (Supplementary
Figures 4A,B), as we had also observed in PND25 mice
(Figures 3–5). Moreover, no changes in mRNA levels for Pvalb,
Kcnc1 Kcns3, Hcn1 and Hcn4 were detected between WT and
Cntnap2−/− mice in the cortex at PND70 (Supplementary
Figures 4C,D). Of note, the previously reported differences were
observed in the MGE-derived implanted neurons from WT and
Cntnap2−/− mice and not between endogenous Pvalb neurons
from the two genotypes and might thus explain the apparent
discrepancies (see also Discussion).
“Analogous” Changes in the Striatum of
Mouse ASD Models (Cntnap2−/−,
PV−/−, Shank3B−/−, VPA) May Hint
Toward Points of Convergence
Based on the hypothesis that various genetic and environmental
ASD mouse models might entail similar alterations in the
expression levels of proteins present in Pvalb neurons and/or in
Pvalb neuron networks, transcript levels of the selective Pvalb
neuron markers Kcnc1 and Kcns3, and HCN family members
(Hcn1, Hcn2, and Hcn4) in the striatum and cortex were
quantified in PV−/− and Shank3B−/− mice and compared to
results obtained in Cntnap2−/− mice, the latter also shown in
Figures 2D,E). While Kcns3 transcript levels were unchanged in
both brain regions of PV−/−, Shank3B−/− and Cntnap2−/−
mice compared to WT mice (Figures 6A,C) and thus supporting
the previously drawn conclusion that there is no loss of Pvalb
neurons in these ASD mouse models (Filice et al., 2016), there
was a trend toward decreased expression of Kcnc1 in the cortex of
PV−/−mice (p = 0.0885; Figure 6C). A similar down-regulation
of Kcnc1 transcript and KV3.1 protein had been observed
before in the cortex of VPA-exposed mice (Lauber et al., 2016).
mRNA levels for Hcn1, Hcn2 and Hcn4 were unchanged in
the cortex of all 3 ASD models (Figure 6D). Levels for Hcn2
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FIGURE 4 | (A) Left: Stereological estimations of PV+ (black) and VVA+ (gray) cells in the mPFC of PND25 WT (N = 6) and Cntnap2–/– (N = 5) mice. Middle:
percentage of PV+ cells surrounded by VVA (black) and VVA+ cells showing PV expression (gray) in WT and Cntnap2–/– mice. Right: Volume of the ROI; i.e., the
mPFC. (B) Representative PV immunofluorescence images from the mPFC of a WT and Cntnap2–/– mouse. ROIs are indicated with dashed lines (sections are
located at Bregma 1.70 mm). Scale bar: 500 µm. All data are expressed as mean ± SEM.
were also similar in the striatum of all investigated models;
however Hcn1 expression levels were prominently decreased in
Shank3B−/− mice (∼50%, p = 0.0113). Although Hcn1 signals
were rather weak in the striatum, the finding of altered Hcn1
levels in Shank3B−/− mice is of interest, since Hcn-mediated
Ih-channelopathy was previously suggested to be a main driver
for the ASD phenotype observed in Shank3−/− mice (Yi et al.,
2016) (see Discussion). In addition, Hcn4 transcript levels were
significantly lower in the striatum of Cntnap2−/− compared to
WT mice (Figure 6B). While decreases in transcript levels of
Pvalb and Kcnc1 are in most cases also mirrored in lower protein
expression levels (Filice et al., 2016; Lauber et al., 2016), it is
currently unknown whether such a correlation also holds true for
Hcn channels.
In summary, our results suggest that Pvalb-neuron
numbers are not altered in the investigated cortical regions
and moreover that global cortical PV expression levels in
PND25 ± 1 Cntnap2−/− mice are unchanged. Yet in the
striatum of Cntnap2-deficient mice, we found decreased PV
protein expression levels. The implications of striatal PV
down-regulation in the various ASD mouse models are discussed
below.
DISCUSSION
The interest in PV-expressing (Pvalb) interneurons linked to
neurodevelopmental disorders such as ASD and schizophrenia
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FIGURE 5 | RT-qPCR values from cortical samples of PND25 mice representing mRNA levels for (A) Pvalb, (C) Gad67, (D) Left: Kcnc1; Middle: Kcnc2; Right:
Kcns3, (E) Left: Hcn1; Middle: Hcn2; Right: Hcn4. Signals were normalized to Rn18S mRNA levels and expressed as fold change compared to WT (N = 6 mice
each). (B) Left: Quantitative Western blot analysis of cortical samples of PND25 WT and Cntnap2–/– mice (N = 6 mice each). Quantification of PV protein levels in the
cortex is shown. GAPDH signals served as loading controls and were used for the normalization of PV protein signals. Results are expressed as a percentage of
normalized PV/GAPDH signals in the WT group. Right: Representative Western blot signals for PV and GAPDH are shown. All data are expressed as mean ± SEM.
has steadily grown over the past years. The number of PV+
neurons was reported to be decreased in human ASD patients
(Hashemi et al., 2016) and several ASD mouse models (see
Table 1 in Wöhr et al., 2015). In most cases, this decrease
was assumed to be the result of partial Pvalb neuron loss.
Noteworthy, RNA-seq and RT-qPCR analyses on post-mortem
tissue samples of temporal and frontal cortex as well as
cerebellum from 48 ASD patients and 49 healthy controls
showed that the PVALB gene was in the group of most
strongly down-regulated genes in the ASD group (Parikshak
et al., 2016). So far, mutations in the PVALB gene have not
been reported in human ASD patients. Nonetheless, mice with
decreased or absent PV levels (PV+/− and PV−/−) show a
strong behavioral ASD phenotype and moreover, ASD-associated
neuroanatomical changes (Wöhr et al., 2015). These findings
support the hypothesis that PV may represent a promising
molecular target providing a common endpoint for at least some
forms of ASD.
Here, we showed that the number of PV+ cells is reduced in
the striatum of Cntnap2−/−mice at PND25± 1. The time point
was chosen, since PV expression and the electrophysiological
maturation of Pvalb neurons reach adult levels at this age (de
Lecea et al., 1995; Okaty et al., 2009). Additionally, at this
age, mice with reduced or absent PV levels (PV+/−, PV−/−)
manifest an ASD-like behavioral phenotype (Wöhr et al., 2015;
Filice et al., 2018). The decrease in PV+ cells is the result of PV
down-regulation and not due to a partial loss of Pvalb neurons,
since the number of VVA+ cells serving as a proxy measure
of striatal Pvalb neurons (Hartig et al., 1992) was unchanged
between WT and Cntnap2−/− mice. Also transcript levels for
specific and well-described Pvalb neuron markers such as KV3.1
(Kcnc1) and KV9.3 (Kcns3) were unaltered in the striatum of
Cntnap2−/− mice. In order to understand the mechanisms
and the functional consequences of Cntnap2-deficiency resulting
in a behavioral ASD-like phenotype in mice, the distinction
between Pvalb neuron loss vs. PV-downregulation is of utmost
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FIGURE 6 | RT-qPCR values from striatal and cortical samples of WT, PV–/–, Shank3B–/–, and Cntnap2–/– PND25 mice representing mRNA levels for (A)
and (C) Left: Kcnc1; Right: Kcns3, (B) and (D) Left: Hcn1; Middle: Hcn2; Right: Hcn4. Signals were normalized to Gapdh (striatum) or Rn18S (cortex) mRNA levels
and expressed as fold change compared to WT (N = 5 mice each). All data are expressed as mean ± SEM.
relevance. A “simple” loss of inhibitory interneurons such as
the Pvalb subtype is expected to result in a decrease of the
inhibitory tone in the brain. In contrast, Pvalb neurons with
decreased or absent PV expression were consistently found to
exhibit enhanced short-term facilitation (Schwaller, 2012; Orduz
et al., 2013), hence increasing the inhibitory tone. Recently, by
using fiber photometry, unperturbed Pvalb neuronal activity in
the mPFC of freely moving Cntnap2−/− and WT mice was
recorded, when mice were confronted with different social and
non-social stimuli (Selimbeyoglu et al., 2017). Distinct activity
patterns were observed in the two groups in response to the
different stimuli, suggesting that the underlying neural dynamics
of Pvalb neurons in the mPFC differed between genotypes.
Additionally, expression of stabilized step-function opsin (SSFO)
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in Pvalb neurons allowed to optogenetically increasing Pvalb
neuron excitability in the mPFC, which rescued the social
deficits prevailing in Cntnap2−/− mice and was associated with
reduced activity of cortico-striatal projections. This finding is
in line with the hypothesis that reduced PV levels are another
mean of enhancing the output of PV neurons in order to
increase the inhibitory tone in the brain, according to the
notion of homeostatic plasticity (Turrigiano, 2011). Interestingly,
human patients carrying mutations affecting the CNTNAP2
locus and adult (>6 month) Cntnap2−/− mice display frequent
and severe seizures (Strauss et al., 2006; Penagarikano et al.,
2011), a state generally linked to an altered excitation/inhibition
balance. Optogenetically enhancing Pvalb neuron excitability
(i.e., enhancing inhibition) shown to rescue social deficits in
Cntnap2−/− mice (Selimbeyoglu et al., 2017), might also have
an effect on seizure severity, yet this remains to be proven
experimentally. Of note, in PND25 Cntnap2−/−mice, we found
no indication of cortical PV down-regulation, thus cortical
alterations in Pvalb neuron excitability –if present– may not be
linked to PV expression; whereas the reduction of PV levels in
striatal Pvalb neurons likely increases excitability as shown before
in the same neuron population in PV−/− mice (Orduz et al.,
2013). Striatal PV downregulation was found to be a common
feature in several prototypical and well-established mouse ASD
models. In addition to the present findings in Cntnap2−/−mice,
also in Shank3B−/− and in utero VPA-exposed mice, reduced
PV levels (in the order of ∼25–50%) and unaltered numbers of
Pvalb neurons were reported (Filice et al., 2016; Lauber et al.,
2016). This suggests that in these ASD models, the striatum
is a particularly susceptible region and that it might play an
important role in the development/manifestation of ASD core
symptoms in mice. The basal ganglia, where the striatum serves as
input structure, have developed to a complex circuitry in higher
vertebrates not only mediating motor output control, but also
higher cognitive functions such as sensory processing, learning,
and memory tasks as well as the generation of intentional and
motivated behaviors in a reward-guided manner (Fuccillo, 2016).
There is substantial clinical evidence that striatal dysfunction
is associated with ASD. Several MRI studies reported about
alterations in the volume of the caudate nucleus or putamen
(Langen et al., 2007, 2014; Estes et al., 2011) and enhanced striatal
connectivity in ASD patients compared to healthy controls
(Di Martino et al., 2011). Abnormalities in striatal structure
and function have moreover been described for several ASD
mouse or rat models, including Shank3−/− mice (Peca et al.,
2011; Jaramillo et al., 2016) and in utero VPA-exposed rats
(Schneider et al., 2007). Recently, it was demonstrated that
targeted depletion of PV-expressing fast-spiking interneurons
(FSIs) and large cholinergic interneurons (CINs) specifically in
the dorsal striatum of mice leads to spontaneous stereotypy and
marked impairments in social interactions (Rapanelli et al., 2017).
Currently, reports about Cntnap2−/−mice in relation to ASD
are still sparse. Cntnap2 is a member of the neurexin family of
synaptic cell adhesion molecules involved in the clustering of K+
channels in myelinated axons (Poliak et al., 1999, 2003). However,
since myelination takes place postnatally and Cntnap2 is strongly
expressed during embryonic development, Cntnap2 is expected
to fulfill additional functions in early brain development. This
assumption is reinforced by the rising number of reports linking
mutations in the CNTNAP2 locus with ASD (Rodenas-Cuadrado
et al., 2014). Three independent studies reported about reduced
spine density in neurons derived from Cntnap2-deficient mice
relative to controls, associated with a decrease in synaptic
transmission (Anderson et al., 2012; Gdalyahu et al., 2015; Varea
et al., 2015). Also perisomatic evoked IPSCs were found to be
significantly reduced in hippocampal slices of Cntnap2−/−mice
(Jurgensen and Castillo, 2015).
During human and mouse embryonic development, Cntnap2
shows enriched expression in the frontal lobe, striatum and
thalamus (Abrahams et al., 2007; Alarcon et al., 2008). Within the
cortex, Cntnap2 is particularly abundant in certain interneuron
subpopulations: in chandelier cells and PV+ neurons, as well as
in VIP (CR+ and CCK+) cells (Vogt et al., 2017). The lack of
Cntnap2 leads to a decrease in the number of PV+ neurons,
which was interpreted as a defect in the differentiation and/or
activity of Pvalb neurons resulting secondarily in decreased PV
expression (Vogt et al., 2017) evidenced at PND14. In line, a
delayed maturation of Pvalb neurons associated with impaired
PV circuit function in ASD has been reported before, e.g., in
Shank3−/− mice (Gogolla et al., 2014). As mentioned before,
the cortico-striato-thalamic circuitry is crucially involved in
higher order cognitive functions and Cntnap2 appears to be
particularly important for language development, since most
human patients with Cntnap2 mutations manifest some sort of
language impairment (see Table 1 in Penagarikano et al., 2015).
Compared to WT mice, Cntnap2−/− mice emit less ultrasonic
vocalizations in the isolation-induced pup vocalization test
(Penagarikano et al., 2011), as well as in response to the female
urine stimulus (Brunner et al., 2015). Interestingly, Cntnap2
is also highly expressed within the cortico-striato-thalamic
circuitry of the zebra finch songbird, a popular animal model
for vocal learning (Panaitof et al., 2010). Lesioning of the
lateral magnocellular nucleus of the anterior neostriatum in
songbirds results in songs with monotonous repetitions of
a single note complex (Scharff and Nottebohm, 1991), thus
providing an additional connection between striatal Cntnap2
expression deficits and language-related impairments. Taken
together, decreased/absent Cntnap2 expression and/or striatal
impairments seem to be potent inducers of ASD core symptoms,
with language dysfunction being particularly frequent in patients
affected by mutations in the CNTNAP2 gene. The observed
down-regulation of PV in the striatum of Cntnap2−/− mice
may thus represent an adaptive mechanism to counteract
reduced inhibition, as observed in the hippocampus of these
mice (Jurgensen and Castillo, 2015), and thus keeping the
excitation/inhibition balance within a correct physiological
window.
Striatal PV down-regulation during early postnatal
development does not seem to be the only similarity between
Cntnap2−/− mice, Shank3B−/− and VPA-exposed mice. Using
human and mouse neurons, Yi et al. (2016) demonstrated that
mutations in Shank3 predispose to ASD possibly by inducing
a severe Ih-channelopathy. Hyperpolarization-activated cation
(Ih) currents, which are mediated by hyperpolarization-activated
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cyclic nucleotide-gated (HCN) channels, regulate membrane
resting potentials, input resistance, neuronal excitability and
synaptic transmission (Biel et al., 2009). Neurons derived from
Shank3−/− mice were found to exhibit severely decreased
Ih currents and furthermore, decreased Hcn4 protein levels
in vitro (Yi et al., 2016). When quantifying mRNA levels of
the Hcn isoforms 1, 2 and 4 in the cortex and striatum of
Cntnap2−/− mice, we found reduced mRNA levels of Hcn4
exclusively in the striatum of Cntnap2−/− mice compared
to WT animals, while mRNA levels of the other isoforms
were unchanged in both brain regions. Therefore, putative
impairments in Hcn-mediated Ih currents might also contribute
to the phenotype of Cntnap2−/− mice. Of note, the observed
changes in striatal Hcn4 transcript levels are but a first hint
toward possible alterations in the striatum of these mice.
Whether Hcn4 protein levels are altered, in which neuron
population and to which extend Ih currents are functionally
altered in Cntnap2−/− mice, remains to be thoroughly
investigated.
In summary, we show that Cntnap2−/− mice display
down-regulation of PV expression in the striatum, a brain
structure with enriched Cntnap2 expression during early
development and functional importance for higher cognitive
functions in later life. Striatal PV down-regulation moreover
seems to occur in various ASD mouse models including
Cntnap2−/−, Shank3B−/−, in utero VPA-exposed (and
evidently PV−/−) mice. Moreover, striatal PV down-regulation
was associated with a decrease in Hcn isoform transcripts
in Cntnap2−/− and Shank3B−/− mice, representing
another point of possible convergence in ASD-implicated
mechanisms.
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